Functional roles of BCAR3 in the signaling pathways of insulin leading to DNA synthesis, membrane ruffling and GLUT4 translocation

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 911-916

  Oh, Myung Ju ^a   Yi, Sun Ju ^b   Kim, Hye Sung ^b   Kim, Ji Hyun ^b   Jeong, Young Hwa ^b   van Agthoven, Ton ^c   Jhun, Byung H ^b  

^a Ministry of Food and Drug Safety   (South Korea)

^b Pusan National University   (South Korea)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BCAR3; DNA synthesis; GLUT4 translocation; IGF I; Insulin; Membrane ruffling; Microinjection

Indexed keywords

BREAST CANCER ANTIESTROGEN RESISTANCE 3; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN SH2; SOMATOMEDIN C; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA SYNTHESIS; MICROINJECTION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BCAR3; DNA SYNTHESIS; GLUT4 TRANSLOCATION; IGF-I; INSULIN; MEMBRANE RUFFLING; MICROINJECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; DNA REPLICATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; PROTEIN TRANSPORT; RATS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 84888834902     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.161     Document Type: Article

References (27)

1. Belfiore A., Frasca F. IGF and insulin receptor signaling in breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:381-406.
2. Gallagher E.J., LeRoith D. Minireview: IGF, insulin, and cancer. Endocrinology 2011, 152:2546-2551.
3. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
4. van Agthoven T., van Agthoven T.L., Dekker A., van der Spek P.J., Vreede L., Dorssers L.C. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells. EMBO J. 1998, 17:2799-2808.
5. Felekkis K.N., Narsimhan R.P., Near R., Castro A.F., Zheng Y., Quilliam L.A., Lerner A. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner. Mol. Cancer Res. 2005, 3:32-41.
6. Near R.I., Zhang Y., Makkinje A., Vanden Borre P., Lerner A. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology. J. Cell. Physiol. 2007, 212:655-665.
7. Mace P.D., Wallez Y., Dobaczewska M.K., Lee J.J., Robinson H., Pasquale E.B., Riedl S.J. NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. Nat. Struct. Mol. Biol. 2011, 18:1381-1387.
8. Lu Y., Brush J., Stewart T.A. NSP1 defines a novel family of adaptor proteins linking integrin and tyrosine kinase receptors to the c-Jun N-terminal kinase/stress-activated protein kinase signaling pathway. J. Biol. Chem. 1999, 274:10047-10052.
9. Oh M.J., van Agthoven T., Choi J.E., Jeong Y.J., Chung Y.H., Kim C.M., Jhun B.H. BCAR3 regulates EGF-induced DNA synthesis in normal human breast MCF-12A cells. Biochem. Biophys. Res. Commun. 2008, 375:430-434.
10. Dodelet V.C. A novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1A. J. Biol. Chem. 1999, 274:31941-31946.
11. Makkinje A., Near R.I., Infusini G., Vanden Borre P., Bloom A., Cai D., Costello C.H., Lerner A. AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern. Cell. Signal. 2009, 21:1423-1435.
12. Sun G., Cheng R.I., Chen M., Lim C.J., Pallen C.J. Protein tyrosine phosphatase α phosphotyrosyl-789 binds BCAR3 to position Cas for activation at integrin-mediated focal adhesions. Mol. Cell. Biol. 2012, 32:3776-3789.
13. Jhun B.H., Rose D.W., Seely B.L., Rameh L., Cantley L., Saltiel A.R., Olefsky J.M. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol. Cell. Biol. 1994, 14:7466-7475.
14. Huang J., Imamura T., Babendure J.L., Lu J.C., Olefsky J.M. Disruption of microtubules ablates the specificity of insulin signaling to GLUT4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 2005, 280:42300-42306.
15. Pillay T.S., Xiao S., Keranen L., Olefsky J.M. Regulation of the insulin receptor by protein kinase C isoenzymes: preferential interaction with β isoenzymes and interaction with the catalytic domain of βII. Cell. Signal. 2004, 16:97-104.
16. Nakashima N., Rose D.W., Xiao S., Egawa K., Martin S.S., Haruta T., Saltiel A.R., Olefsky J.M. The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J. Biol. Chem. 1999, 274:3001-3008.
17. Najjar S.M., Blakesley V.A., Li Calzi S., Kato H., LeRoith D., Choice C.V. Differential phosphorylation of pp120 by insulin and insulin-like growth factor-1 receptors: role for the C-terminal domain of the beta-subunit. Biochemistry 1997, 36:6827-6834.
18. O'Neill T.J., Zhu Y., Gustafson T.A. Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation. J. Biol. Chem. 1997, 272:10035-10040.
19. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., Bickel P.E., Pessin J.E., Saltiel A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
20. Hu J., Liu J., Ghirlando R., Saltiel A.R., Hubbard S.R. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol. Cell 2003, 12:1379-1389.
21. Pillay T.S., Sasaoka T., Olefsky J.M. Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase. J. Biol. Chem. 1995, 270:991-994.
22. Schrecengost R.S., Riggins R.B., Thomas K.S., Guerrero M.S., Bouton A.H. Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res. 2007, 67:6174-6182.
23. Wilson A.L., Schrecengost R.S., Guerrero M.S., Thomas K.S., Bouton A.H. Breast cancer antiestrogen resistance 3 (BCAR3) promotes cell motility by regulating actin cytoskeletal and adhesion remodeling in invasive breast cancer cells. PLoS One 2013, 8:e65678.
24. Belfiore A. The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Curr. Pharm. Biotechnol. 2007, 13:671-686.
25. Papa V., Pezzino V., Costantino A., Belfiore A., Giuffrida D., Frittitta L., Vannelli G.B., Brand R., Goldfine I.D., Vigneri R. Elevated insulin receptor content in human breast cancer. J. Clin. Invest. 1990, 1503-1510.
26. Milazzo G., Giorgino F., Damante G., Sung C., Stampfer M.R., Vigneri R., Goldfine I.D., Belfiore A. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res. 1992, 52:3924-3930.
27. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch. Physiol. Biochem. 2008, 114:63-70.